Clinical trial

A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and…

NCT00323635 · Brigham and Women's Hospital, Other · Terminated

Key facts

NCT number NCT00323635
Title A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
Official title A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
Lead sponsor Brigham and Women's Hospital, Other
Collaborators Pfizer Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Urinary Incontinence
Intervention type Drug
Interventions tolterodine
Enrollment 19
Start date Apr 1, 2006
Primary completion Jan 1, 2010
Completion Jan 1, 2011
First posted May 9, 2006
Last update posted Mar 29, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies